← ANALYST RATINGS · TIPRANKS
Agilent (A): analyst forecast and price target
Price targets and ratings of
Analyst consensus
Strong Buy11 Buy2 Hold0 Sell
Ratings of 13 analysts in the last 3 months · top analysts only12-month forecast
$183+6.0% upside
Based on 13 price targets given in the last 3 months, the average target is $183, the highest $196, the lowest $150. The average is +6.0% from the last price of $173.
Highest target $196
Average target $183
Lowest target $150
Analyst ratings 26
| Analyst | Firm | Price target | Rating | Upside | Action | Date | Move vs SPY | |
|---|---|---|---|---|---|---|---|---|
| AI xAi Medical - Diagnostics and ResearchxAI Grok-3 | TipRanks - xAI | $197 → $194−1.5% | Buy | +12.2% | Reiterated | 17.10.26on TipRanks 09:06 | — | |
| AI DeepSeek Medical - Diagnostics and ResearchDeepSeek V3.2-Speciale | TipRanks - DeepSeek | $193 → $190−1.6% | Buy | +9.8% | Reiterated | 17.10.26on TipRanks 09:06 | — | |
| AI OpenAI Medical - Diagnostics and ResearchOpenAI 5.2 | TipRanks - OpenAI | $197 → $195−1.0% | Buy | +12.7% | Reiterated | 17.10.26on TipRanks 09:06 | — | |
| AI Anthropic Medical - Diagnostics and ResearchAnthropic Opus-4.5 | TipRanks - Anthropic | $197 → $195−1.0% | Buy | +12.7% | Reiterated | 17.10.26on TipRanks 09:06 | — | |
| AI Google Medical - Diagnostics and ResearchGemini 3-pro | TipRanks - Google | $200 → $197−1.5% | Buy | +13.9% | Reiterated | 17.10.26on TipRanks 09:06 | — | |
| AI PerPlexity Medical - Diagnostics and ResearchPerPlexity SonarPro | TipRanks - PerPlexity | $203 → $200−1.5% | Buy | +15.6% | Reiterated | 17.10.26on TipRanks 09:06 | — | |
| AI xAi Medical - Diagnostics and ResearchxAI Grok-3 | TipRanks - xAI | $192 → $197+2.6% | Buy | +13.9% | Reiterated | 16.10.26on TipRanks 04:05 | — | |
| AI DeepSeek Medical - Diagnostics and ResearchDeepSeek V3.2-Speciale | TipRanks - DeepSeek | $189 → $193+2.1% | Buy | +11.6% | Reiterated | 16.10.26on TipRanks 04:05 | — | |
| AI OpenAI Medical - Diagnostics and ResearchOpenAI 5.2 | TipRanks - OpenAI | $193 → $197+2.1% | Buy | +13.9% | Reiterated | 16.10.26on TipRanks 04:05 | — | |
| AI Anthropic Medical - Diagnostics and ResearchAnthropic Opus-4.5 | TipRanks - Anthropic | $193 → $197+2.1% | Buy | +13.9% | Reiterated | 16.10.26on TipRanks 04:05 | — | |
| AI Google Medical - Diagnostics and ResearchGemini 3-pro | TipRanks - Google | $196 → $200+2.0% | Buy | +15.6% | Reiterated | 16.10.26on TipRanks 04:05 | — | |
| AI PerPlexity Medical - Diagnostics and ResearchPerPlexity SonarPro | TipRanks - PerPlexity | $198 → $203+2.5% | Buy | +17.4% | Reiterated | 16.10.26on TipRanks 04:05 | — | |
| AI DeepSeek Medical - Diagnostics and ResearchDeepSeek V3.2-Speciale | TipRanks - DeepSeek | $188 → $189+0.5% | Buy | +9.3% | Reiterated | 15.10.26on TipRanks Oct 14 21:05 | — | |
| AI Google Medical - Diagnostics and ResearchGemini 3-pro | TipRanks - Google | $195 → $196+0.5% | Buy | +13.3% | Reiterated | 15.10.26on TipRanks Oct 14 21:05 | — | |
| Doug Schenkel★★★★★★★★★★#216 · hits 65% · avg +26.2% | Wolfe Research | $180 | Hold | +4.1% | Reiterated | 14.10.26on TipRanks 07:11 | +2.5%next day +0.6% | ↗ |
| Michael Ryskin★★★★★★★★★★#1994 · hits 58% · avg +5.1% | Bank of America Securities | $180 → $190+5.6% | Buy | +9.8% | Reiterated | 13.10.26on TipRanks Oct 14 06:35 | +0.2%next day +2.5% | ↗ |
| AI xAi Medical - Diagnostics and ResearchxAI Grok-3 | TipRanks - xAI | $191 → $192+0.5% | Buy | +11.0% | Reiterated | 13.10.26on TipRanks 16:05 | — | |
| AI OpenAI Medical - Diagnostics and ResearchOpenAI 5.2 | TipRanks - OpenAI | $192 → $193+0.5% | Buy | +11.6% | Reiterated | 13.10.26on TipRanks 16:05 | — | |
| AI Anthropic Medical - Diagnostics and ResearchAnthropic Opus-4.5 | TipRanks - Anthropic | $192 → $193+0.5% | Buy | +11.6% | Reiterated | 13.10.26on TipRanks 16:05 | — | |
| AI Google Medical - Diagnostics and ResearchGemini 3-pro | TipRanks - Google | $194 → $195+0.5% | Buy | +12.7% | Reiterated | 13.10.26on TipRanks 16:05 | — | |
| AI PerPlexity Medical - Diagnostics and ResearchPerPlexity SonarPro | TipRanks - PerPlexity | $197 → $198+0.5% | Buy | +14.5% | Reiterated | 13.10.26on TipRanks 16:05 | — | |
| Daniel Brennan★★★★★★★★★★#271 · hits 58% · avg +21.8% | TD Cowen | $180 → $196+8.9% | Buy | +13.3% | Reiterated | 13.10.26on TipRanks 08:41 | +0.2%next day +2.5% | ↗ |
| Kallum Titchmarsh★★★★★★★★★★#2647 · hits 58% · avg +9.6% | Morgan Stanley | $175 → $190+8.6% | Buy | +9.8% | Assigned | 12.10.26on TipRanks 09:30 | +0.5%next day +0.2% | ↗ |
| Eve Burstein★★★★★★★★★★#1300 · hits 72% · avg +25.0% | Bernstein | $180 | Buy | +4.1% | Reiterated | 12.10.26on TipRanks 06:30 | +0.5%next day +0.2% | ↗ |
| AI xAi Medical - Diagnostics and ResearchxAI Grok-3 | TipRanks - xAI | $188 → $191+1.6% | Buy | +10.4% | Reiterated | 11.10.26on TipRanks 02:05 | — | |
| AI DeepSeek Medical - Diagnostics and ResearchDeepSeek V3.2-Speciale | TipRanks - DeepSeek | $185 → $188+1.6% | Buy | +8.7% | Reiterated | 11.10.26on TipRanks 02:05 | — | |
| AI OpenAI Medical - Diagnostics and ResearchOpenAI 5.2 | TipRanks - OpenAI | $189 → $192+1.6% | Buy | +11.0% | Reiterated | 11.10.26on TipRanks 02:05 | — | |
| AI Anthropic Medical - Diagnostics and ResearchAnthropic Opus-4.5 | TipRanks - Anthropic | $189 → $192+1.6% | Buy | +11.0% | Reiterated | 11.10.26on TipRanks 02:05 | — | |
| AI Google Medical - Diagnostics and ResearchGemini 3-pro | TipRanks - Google | $192 → $194+1.0% | Buy | +12.2% | Reiterated | 11.10.26on TipRanks 02:05 | — | |
| AI PerPlexity Medical - Diagnostics and ResearchPerPlexity SonarPro | TipRanks - PerPlexity | $194 → $197+1.5% | Buy | +13.9% | Reiterated | 11.10.26on TipRanks 02:05 | — | |
| AI xAi Medical - Diagnostics and ResearchxAI Grok-3 | TipRanks - xAI | $189 → $188−0.5% | Buy | +8.7% | Reiterated | 10.10.26on TipRanks Oct 9 21:05 | — | |
| AI DeepSeek Medical - Diagnostics and ResearchDeepSeek V3.2-Speciale | TipRanks - DeepSeek | $186 → $185−0.5% | Buy | +7.0% | Reiterated | 10.10.26on TipRanks Oct 9 21:05 | — | |
| AI OpenAI Medical - Diagnostics and ResearchOpenAI 5.2 | TipRanks - OpenAI | $190 → $189−0.5% | Buy | +9.3% | Reiterated | 10.10.26on TipRanks Oct 9 21:05 | — | |
| AI Anthropic Medical - Diagnostics and ResearchAnthropic Opus-4.5 | TipRanks - Anthropic | $190 → $189−0.5% | Buy | +9.3% | Reiterated | 10.10.26on TipRanks Oct 9 21:05 | — | |
| AI Google Medical - Diagnostics and ResearchGemini 3-pro | TipRanks - Google | $193 → $192−0.5% | Buy | +11.0% | Reiterated | 10.10.26on TipRanks Oct 9 21:05 | — | |
| AI PerPlexity Medical - Diagnostics and ResearchPerPlexity SonarPro | TipRanks - PerPlexity | $195 → $194−0.5% | Buy | +12.2% | Reiterated | 10.10.26on TipRanks Oct 9 21:05 | — | |
| Michael Ryskin★★★★★★★★★★#1994 · hits 58% · avg +5.1% | Bank of America Securities | $180 → $190+5.6% | Buy | +9.8% | Reiterated | 09.10.26on TipRanks 08:01 | +0.8%next day +0.5% · 5 days +3.4% | ↗ |
| AI xAi Medical - Diagnostics and ResearchxAI Grok-3 | TipRanks - xAI | $190 → $189−0.5% | Buy | +9.3% | Reiterated | 08.10.26on TipRanks 17:05 | — | |
| AI PerPlexity Medical - Diagnostics and ResearchPerPlexity SonarPro | TipRanks - PerPlexity | $196 → $195−0.5% | Buy | +12.7% | Reiterated | 08.10.26on TipRanks 17:05 | — | |
| AI xAi Medical - Diagnostics and ResearchxAI Grok-3 | TipRanks - xAI | $192 → $190−1.0% | Buy | +9.8% | Reiterated | 07.10.26on TipRanks 15:05 | — | |
| AI DeepSeek Medical - Diagnostics and ResearchDeepSeek V3.2-Speciale | TipRanks - DeepSeek | $188 → $186−1.1% | Buy | +7.5% | Reiterated | 07.10.26on TipRanks 15:05 | — | |
| AI OpenAI Medical - Diagnostics and ResearchOpenAI 5.2 | TipRanks - OpenAI | $193 → $190−1.6% | Buy | +9.8% | Reiterated | 07.10.26on TipRanks 15:05 | — | |
| AI Anthropic Medical - Diagnostics and ResearchAnthropic Opus-4.5 | TipRanks - Anthropic | $193 → $190−1.6% | Buy | +9.8% | Reiterated | 07.10.26on TipRanks 15:05 | — | |
| AI Google Medical - Diagnostics and ResearchGemini 3-pro | TipRanks - Google | $195 → $193−1.0% | Buy | +11.6% | Reiterated | 07.10.26on TipRanks 15:05 | — | |
| AI PerPlexity Medical - Diagnostics and ResearchPerPlexity SonarPro | TipRanks - PerPlexity | $198 → $196−1.0% | Buy | +13.3% | Reiterated | 07.10.26on TipRanks 15:05 | — | |
| Luke Sergott★★★★★★★★★★#1255 · hits 49% · avg +9.8% | Barclays | $175 → $195+11.4% | Buy | +12.7% | Reiterated | 07.10.26on TipRanks 03:55 | +0.1%next day −0.1% · 5 days +3.9% | ↗ |
| AI xAi Medical - Diagnostics and ResearchxAI Grok-3 | TipRanks - xAI | $188 → $192+2.1% | Buy | +11.0% | Reiterated | 06.10.26on TipRanks 12:05 | — | |
| AI DeepSeek Medical - Diagnostics and ResearchDeepSeek V3.2-Speciale | TipRanks - DeepSeek | $185 → $188+1.6% | Buy | +8.7% | Reiterated | 06.10.26on TipRanks 12:05 | — | |
| AI OpenAI Medical - Diagnostics and ResearchOpenAI 5.2 | TipRanks - OpenAI | $189 → $193+2.1% | Buy | +11.6% | Reiterated | 06.10.26on TipRanks 12:05 | — | |
| AI Anthropic Medical - Diagnostics and ResearchAnthropic Opus-4.5 | TipRanks - Anthropic | $189 → $193+2.1% | Buy | +11.6% | Reiterated | 06.10.26on TipRanks 12:05 | — | |
| AI Google Medical - Diagnostics and ResearchGemini 3-pro | TipRanks - Google | $191 → $195+2.1% | Buy | +12.7% | Reiterated | 06.10.26on TipRanks 12:05 | — | |
| AI PerPlexity Medical - Diagnostics and ResearchPerPlexity SonarPro | TipRanks - PerPlexity | $194 → $198+2.1% | Buy | +14.5% | Reiterated | 06.10.26on TipRanks 12:05 | — | |
| AI xAi Medical - Diagnostics and ResearchxAI Grok-3 | TipRanks - xAI | $187 → $188+0.5% | Buy | +8.7% | Reiterated | 04.10.26on TipRanks 01:05 | — | |
| AI DeepSeek Medical - Diagnostics and ResearchDeepSeek V3.2-Speciale | TipRanks - DeepSeek | $183 → $185+1.1% | Buy | +7.0% | Reiterated | 04.10.26on TipRanks 01:05 | — | |
| AI OpenAI Medical - Diagnostics and ResearchOpenAI 5.2 | TipRanks - OpenAI | $188 → $189+0.5% | Buy | +9.3% | Reiterated | 04.10.26on TipRanks 01:05 | — | |
| AI Anthropic Medical - Diagnostics and ResearchAnthropic Opus-4.5 | TipRanks - Anthropic | $188 → $189+0.5% | Buy | +9.3% | Reiterated | 04.10.26on TipRanks 01:05 | — | |
| AI Google Medical - Diagnostics and ResearchGemini 3-pro | TipRanks - Google | $190 → $191+0.5% | Buy | +10.4% | Reiterated | 04.10.26on TipRanks 01:05 | — | |
| AI PerPlexity Medical - Diagnostics and ResearchPerPlexity SonarPro | TipRanks - PerPlexity | $193 → $194+0.5% | Buy | +12.2% | Reiterated | 04.10.26on TipRanks 01:05 | — | |
| AI xAi Medical - Diagnostics and ResearchxAI Grok-3 | TipRanks - xAI | $193 → $187−3.1% | Buy | +8.1% | Reiterated | 03.10.26on TipRanks Oct 2 23:06 | — | |
| AI DeepSeek Medical - Diagnostics and ResearchDeepSeek V3.2-Speciale | TipRanks - DeepSeek | $190 → $183−3.7% | Buy | +5.8% | Reiterated | 03.10.26on TipRanks Oct 2 23:06 | — | |
| AI OpenAI Medical - Diagnostics and ResearchOpenAI 5.2 | TipRanks - OpenAI | $194 → $188−3.1% | Buy | +8.7% | Reiterated | 03.10.26on TipRanks Oct 2 23:06 | — | |
| AI Anthropic Medical - Diagnostics and ResearchAnthropic Opus-4.5 | TipRanks - Anthropic | $194 → $188−3.1% | Buy | +8.7% | Reiterated | 03.10.26on TipRanks Oct 2 23:06 | — | |
| AI Google Medical - Diagnostics and ResearchGemini 3-pro | TipRanks - Google | $196 → $190−3.1% | Buy | +9.8% | Reiterated | 03.10.26on TipRanks Oct 2 23:06 | — | |
| AI PerPlexity Medical - Diagnostics and ResearchPerPlexity SonarPro | TipRanks - PerPlexity | $199 → $193−3.0% | Buy | +11.6% | Reiterated | 03.10.26on TipRanks Oct 2 23:06 | — | |
| AI xAi Medical - Diagnostics and ResearchxAI Grok-3 | TipRanks - xAI | $196 → $193−1.5% | Buy | +11.6% | Reiterated | 02.10.26on TipRanks Oct 1 21:05 | — | |
| AI DeepSeek Medical - Diagnostics and ResearchDeepSeek V3.2-Speciale | TipRanks - DeepSeek | $193 → $190−1.6% | Buy | +9.8% | Reiterated | 02.10.26on TipRanks Oct 1 21:05 | — | |
| AI OpenAI Medical - Diagnostics and ResearchOpenAI 5.2 | TipRanks - OpenAI | $197 → $194−1.5% | Buy | +12.2% | Reiterated | 02.10.26on TipRanks Oct 1 21:05 | — | |
| AI Anthropic Medical - Diagnostics and ResearchAnthropic Opus-4.5 | TipRanks - Anthropic | $197 → $194−1.5% | Buy | +12.2% | Reiterated | 02.10.26on TipRanks Oct 1 21:05 | — | |
| AI Google Medical - Diagnostics and ResearchGemini 3-pro | TipRanks - Google | $200 → $196−2.0% | Buy | +13.3% | Reiterated | 02.10.26on TipRanks Oct 1 21:05 | — | |
| AI PerPlexity Medical - Diagnostics and ResearchPerPlexity SonarPro | TipRanks - PerPlexity | $202 → $199−1.5% | Buy | +15.0% | Reiterated | 02.10.26on TipRanks Oct 1 21:05 | — | |
| AI xAi Medical - Diagnostics and ResearchxAI Grok-3 | TipRanks - xAI | $196 | Buy | +13.3% | Reiterated | 30.09.26on TipRanks 20:05 | — | |
| AI DeepSeek Medical - Diagnostics and ResearchDeepSeek V3.2-Speciale | TipRanks - DeepSeek | $193 | Buy | +11.6% | Reiterated | 30.09.26on TipRanks 20:05 | — | |
| AI OpenAI Medical - Diagnostics and ResearchOpenAI 5.2 | TipRanks - OpenAI | $197 | Buy | +13.9% | Reiterated | 30.09.26on TipRanks 20:05 | — | |
| AI Anthropic Medical - Diagnostics and ResearchAnthropic Opus-4.5 | TipRanks - Anthropic | $197 | Buy | +13.9% | Reiterated | 30.09.26on TipRanks 20:05 | — | |
| AI Google Medical - Diagnostics and ResearchGemini 3-pro | TipRanks - Google | $200 | Buy | +15.6% | Reiterated | 30.09.26on TipRanks 20:05 | — | |
| AI PerPlexity Medical - Diagnostics and ResearchPerPlexity SonarPro | TipRanks - PerPlexity | $202 | Buy | +16.8% | Reiterated | 30.09.26on TipRanks 20:05 | — | |
| Michael Ryskin★★★★★★★★★★#1994 · hits 58% · avg +5.1% | Bank of America Securities | $180 | Buy | +4.1% | Reiterated | 28.09.26on TipRanks 06:25 | +2.1%next day +0.1% · 5 days −3.4% | ↗ |
| Eve Burstein★★★★★★★★★★#1300 · hits 72% · avg +25.0% | Bernstein | $180 | Buy | +4.1% | Reiterated | 25.09.26on TipRanks Sep 26 08:40 | −0.6%next day +2.1% · 5 days −2.7% | ↗ |
| Evie Koslosky★★★★★★★★★★#9740 · hits 58% · avg −3.1% | Goldman Sachs | $175 → $185+5.7% | Buy | +7.0% | Reiterated | 20.09.26on TipRanks Sep 21 08:15 | +1.9%next day +3.3% · 5 days +9.2% | ↗ |
| John Dunigan★★★★★★★★★★#4346 · hits 100% · avg +37.0% | Jefferies | $181 | Hold | +4.6% | Reiterated | 17.09.26on TipRanks 09:26 | +0.6%next day 0.0% · 5 days +9.7% | ↗ |
| Unknown Analyst | UBS | $165 | Hold | −4.6% | Initiated | 08.09.26on TipRanks Sep 9 06:45 | −2.1%next day −1.0% · 5 days +3.4% | ↗ |
| Kallum Titchmarsh★★★★★★★★★★#2647 · hits 58% · avg +9.6% | Morgan Stanley | $175 | Buy | +1.2% | Reiterated | 01.09.26on TipRanks 08:10 | −1.7%next day +0.5% · 5 days −3.5% | ↗ |
| Daniel Arias★★★★★★★★★★#1848 · hits 50% · avg +8.0% | Stifel Nicolaus | $180 | Buy | +4.1% | Reiterated | 30.08.26on TipRanks 22:05 | +0.1%next day −1.7% · 5 days −4.2% | ↗ |
| Luke Sergott★★★★★★★★★★#1255 · hits 49% · avg +9.8% | Barclays | $150 → $175+16.7% | Buy | +1.2% | Reiterated | 27.08.26on TipRanks 11:25 | +1.0%next day −2.2% · 5 days −5.2% | ↗ |
| David Westenberg★★★★★★★★★★#602 · hits 56% · avg +17.3% | Piper Sandler | $150 | Hold | −13.3% | Reiterated | 27.08.26on TipRanks 07:55 | +1.0%next day −2.2% · 5 days −5.2% | ↗ |
| Vijay Kumar★★★★★★★★★★#2375 · hits 54% · avg +4.8% | Evercore ISI | $148 → $172+16.2% | Buy | −0.6% | Reiterated | 27.08.26on TipRanks 07:55 | +1.0%next day −2.2% · 5 days −5.2% | ↗ |
| Daniel Brennan★★★★★★★★★★#271 · hits 58% · avg +21.8% | TD Cowen | $155 → $180+16.1% | Buy | +4.1% | Assigned | 27.08.26on TipRanks 07:30 | +1.0%next day −2.2% · 5 days −5.2% | ↗ |
| Casey Woodring★★★★★★★★★★#2489 · hits 62% · avg +8.2% | J.P. Morgan | $180 → $190+5.6% | Buy | +9.8% | Reiterated | 27.08.26on TipRanks 07:25 | +1.0%next day −2.2% · 5 days −5.2% | ↗ |
| Patrick B Donnelly★★★★★★★★★★#2106 · hits 54% · avg +6.0% | Citi | $185 → $190+2.7% | Buy | +9.8% | Reiterated | 27.08.26on TipRanks 07:00 | +1.0%next day −2.2% · 5 days −5.2% | ↗ |
| Dan Leonard★★★★★★★★★★#656 · hits 62% · avg +14.1% | RBC Capital | $155 → $185+19.4% | Buy | +7.0% | Reiterated | 26.08.26on TipRanks Aug 27 07:15 | +0.2%next day +1.0% · 5 days −2.3% | ↗ |
| Sidharth Sahoo★★★★★★★★★★#9090 · hits 43% · avg −0.9% | HSBC | $180 → $165−8.3% | Buy | −4.6% | Reiterated | 03.06.26on TipRanks 05:35 | +2.4%next day +0.3% · 5 days −0.4% | ↗ |
| Michael Polark★★★★★★★★★★#2909 · hits 51% · avg +6.5% | Wolfe Research | $135 | Hold | −22.0% | Initiated | 01.06.26on TipRanks 16:35 | −0.8%next day +2.4% · 5 days +3.3% | ↗ |
| Brandon Couillard★★★★★★★★★★#287 · hits 63% · avg +18.4% | Wells Fargo | $165 → $160−3.0% | Buy | −7.5% | Reiterated | 28.05.26on TipRanks 06:35 | +16.3%next day −0.1% · 5 days +1.9% | ↗ |
| Catherine Ramsey Schulte★★★★★★★★★★#864 · hits 53% · avg +11.2% | Robert W. Baird | $155 → $156+0.6% | Buy | −9.8% | Reiterated | 26.05.26on TipRanks 06:55 | −0.6%next day +0.7% · 5 days +16.2% | ↗ |
| Jack Meehan★★★★★★★★★★#787 · hits 68% · avg +14.4% | Nephron | $145 | Buy | −16.2% | Upgrade | 26.03.26on TipRanks 07:20 | +2.2%next day −1.1% · 5 days +0.3% | ↗ |
| No ratings for this filter. | ||||||||
Every rating the collector has kept for the last 12 months, including the earlier ones of the same analyst. Latest of each analyst
Best analysts covering Agilent
TipRanks picks them by their record on this stock; the figures under the name are their record across all their ratings.
Most accurate
Most profitable
How the average price target moved
The average target of all analysts (their ratings of the 3 months before) on each day, the top analysts’ dashed, against the price; the site keeps this record since 1 October 2026. On 01.10.26: target $178 at a price of $172 (+3.1%); now: $183 at $173 (+5.9%).
PriceAverage targetTop analysts’ target
Recommendation trend · top analysts
Strong BuyBuyHoldSell
| Rating | 05.26 | 06.26 | 07.26 | 08.26 | 09.26 | 10.26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 1 | 0 | 0 |
| Buy | 15 | 14 | 14 | 18 | 20 | 23 |
| Hold | 0 | 2 | 3 | 4 | 4 | 4 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Earnings and sales forecast
Next report: 30.11.26 (Q4 2026, date not confirmed)
Earnings per share
Next quarter’s EPS estimate — $1.73 (from $1.71 to $1.74). Last quarter: $1.62.
Sales
Next quarter’s sales estimate — $2.0B (from $2.0B to $2.0B). Last quarter: $1.9B.
Best top-analyst consensus in the sector · Healthcare
About Agilent
- CEO: Padraig McDonnell
- Employees: 18,200
- 5301 Stevens Creek Boulevard, Santa Clara, CA, 95051, US
- www.agilent.com
Agilent Technologies, Inc. delivers specialized, application-focused technologies and services to the global life sciences, diagnostics, and applied chemistry industries. Its Life Sciences and Applied Markets segment provides a comprehensive portfolio of analytical instrumentation. This includes liquid chromatography (LC) and gas chromatography (GC) systems, often integrated with mass spectrometry (MS) for advanced analysis (LC-MS, GC-MS). They also offer inductively coupled plasma mass spectrometry (ICP-MS), atomic absorption (AA), microwave plasma-atomic emission spectrometry (MP-AES), and inductively coupled plasma optical emission spectrometry (ICP-OES) instruments, alongside Raman spectroscopy for material characterization. Beyond spectroscopy, the segment supplies cell analysis solutions such as plate-based assays, flow cytometers, real-time cell analyzers, imaging systems, and microplate readers. Complementing these are various laboratory software, information management platforms, data analytics tools, automated and robotic lab systems, dissolution testing equipment, vacuum technology, and general measurement solutions. The Diagnostics and Genomics division offers cutting-edge tools for genetic and diagnostic research. These encompass arrays designed for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, and gene expression analysis. This segment also provides target enrichment solutions for next-generation sequencing, along with software for genetic data management and interpretation. Furthermore, it synthesizes custom oligonucleotides. Other significant offerings include immunohistochemistry (IHC), in situ hybridization (ISH), hematoxylin and eosin (H&E) staining, and specialized staining solutions. The division also supplies consumables and software essential for quality control analysis of nucleic acid samples, as well as reagents for turbidimetry and flow cytometry applic
Data from the stock’s TipRanks forecast page, read 0 min ago. It is read again as soon as a new rating appears and at least every 8 hours. TipRanks ↗